Brokerages Set Transcat, Inc. (NASDAQ:TRNS) Price Target at $111.50

Transcat, Inc. (NASDAQ:TRNS) has been given an average rating of “Hold” by the five research firms that are covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $111.50.

TRNS has been the topic of several research reports. Northland Securities restated a “market perform” rating and set a $85.00 price objective (down previously from $110.00) on shares of Transcat in a report on Wednesday, January 29th. StockNews.com downgraded shares of Transcat from a “hold” rating to a “sell” rating in a report on Wednesday, February 5th. Oppenheimer downgraded shares of Transcat from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 29th. Craig Hallum upped their price objective on shares of Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a report on Thursday, December 12th. Finally, HC Wainwright lowered their price objective on shares of Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a report on Wednesday, January 29th.

Insider Activity

In other news, Director Craig D. Cairns bought 1,200 shares of the stock in a transaction dated Friday, January 31st. The stock was bought at an average price of $77.02 per share, for a total transaction of $92,424.00. Following the completion of the acquisition, the director now directly owns 1,910 shares in the company, valued at approximately $147,108.20. This trade represents a 169.01 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 2.30% of the stock is currently owned by corporate insiders.

Institutional Trading of Transcat

Several institutional investors and hedge funds have recently made changes to their positions in the company. Conestoga Capital Advisors LLC raised its holdings in shares of Transcat by 17.9% in the third quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock valued at $109,561,000 after purchasing an additional 137,830 shares during the last quarter. Neuberger Berman Group LLC increased its holdings in Transcat by 1.8% during the fourth quarter. Neuberger Berman Group LLC now owns 873,985 shares of the scientific and technical instruments company’s stock worth $92,415,000 after buying an additional 15,723 shares during the last quarter. Champlain Investment Partners LLC increased its holdings in Transcat by 35.7% during the fourth quarter. Champlain Investment Partners LLC now owns 555,650 shares of the scientific and technical instruments company’s stock worth $58,754,000 after buying an additional 146,150 shares during the last quarter. T. Rowe Price Investment Management Inc. increased its holdings in Transcat by 178.0% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 518,597 shares of the scientific and technical instruments company’s stock worth $54,837,000 after buying an additional 332,064 shares during the last quarter. Finally, Royce & Associates LP increased its holdings in Transcat by 8.2% during the third quarter. Royce & Associates LP now owns 511,701 shares of the scientific and technical instruments company’s stock worth $61,798,000 after buying an additional 38,774 shares during the last quarter. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Transcat Stock Up 3.7 %

Shares of NASDAQ TRNS opened at $82.80 on Friday. The firm has a market cap of $770.79 million, a PE ratio of 44.76 and a beta of 0.68. Transcat has a 12-month low of $73.37 and a 12-month high of $147.12. The company’s fifty day simple moving average is $95.03 and its 200 day simple moving average is $108.75. The company has a quick ratio of 1.98, a current ratio of 2.42 and a debt-to-equity ratio of 0.14.

Transcat (NASDAQ:TRNS) last issued its earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same quarter last year, the firm earned $0.56 EPS. As a group, sell-side analysts forecast that Transcat will post 2.3 earnings per share for the current fiscal year.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.